Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans

Eukaryotic Cell

Volumn 8, Issue 8, 2009, Pages 1164-1173

  Grijpstra, Jan ^a   Gerwig, Gerrit J ^b   Wösten, Han ^a   Kamerling, Johannis P ^b   De Cock, Hans ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FILOBASIDIELLA NEOFORMANS;

FUNGAL PROTEIN; POLYSACCHARIDE;

ARTICLE; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; EXTRACELLULAR SPACE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MUTATION; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CRYPTOCOCCUS NEOFORMANS; EXTRACELLULAR SPACE; FUNGAL PROTEINS; MUTATION; POLYSACCHARIDES;

EID: 68549109569     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00013-09     Document Type: Article

References (52)

1. Beverley, S. M., K. L. Owens, M. Showalter, C. L. Griffith, T. L. Doering, V. C. Jones, and M. R. McNeil. 2005. Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens. Eukaryot. Cell 4:1147-1154.
2. Bhattacharjee, A. K., J. E. Bennett, and C. P. Glaudemans. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619-624.
3. Bose, I., A. J. Reese, J. J. Ory, G. Janbon, and T. L. Doering. 2003. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot. Cell 2:655-663.
4. Bretaudeau, K., O. Eloy, A. Richer, F. Bruneel, D. Scott-Algara, O. Lortholary, and F. Pico. 2006. Cryptococcal meningo-encephalitis in an apparently immunocompetent patient. Rev. Neurol. (Paris) 162:233-237. (In French.)
5. Buchanan, K. L., and J. W. Murphy. 1998. What makes Cryptococcus neoformans a pathogen? Emerg. Infect. Dis. 4:71-83.
6. Bystricky, S., E. Paulovicova, and E. Machova. 2004. Synthesis and immunogenicity of polysaccharide-protein conjugate composed of galactoglucoxylomannan of Cryptococcus laurentii. FEMS Microbiol. Lett. 235:311-314.
7. Chang, Y. C., R. Cherniak, T. R. Kozel, D. L. Granger, L. C. Morris, L. C. Weinhold, and K. J. Kwon-Chung. 1997. Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene. Infect. Immun. 65:1584-1592.
8. Chang, Y. C., A. Jong, S. Huang, P. Zerfas, and K. J. Kwon-Chung. 2006. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect. Immun. 74:3930-3938.
9. Chang, Y. C., and K. J. Kwon-Chung. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
10. Chang, Y. C., and K. J. Kwon-Chung. 1998. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 66:2230-2236.
11. Chang, Y. C., and K. J. Kwon-Chung. 1999. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neofor-mans. J. Bacteriol. 181:5636-5643.
12. Chang, Y. C., L. A. Penoyer, and K. J. Kwon-Chung. 1996. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 64:1977-1983.
13. Chang, Y. C., B. L. Wickes, and K. J. Kwon-Chung. 1995. Further analysis of the CAP59 locus of Cryptococcus neoformans: structure defined by forced expression and description of a new ribosomal protein-encoding gene. Gene 167:179-183.
14. Cherniak, R., R. G. Jones, and E. Reiss. 1988. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy. Carbohydr. Res. 172:113-138.
15. Cherniak, R., L. C. Morris, B. C. Anderson, and S. A. Meyer. 1991. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect. Immun. 59:59-64.
16. Cherniak, R., E. Reiss, and S. H. Turner. 1982. A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr. Res. 103:239-250.
17. Cherniak, R., and J. B. Sundstrom. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512.
18. Cherniak, R., H. Valafar, L. C. Morris, and F. Valafar. 1998. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin. Diagn. Lab Immunol. 5:146-159.
19. Chute, H. L., F. L. Davis, and D. D. Payne. 1965. Cryptococcosis, a disease of man and animals. J. Maine Med. Assoc. 56:228-229.
20. Coenjaerts, F. E., A. M. Walenkamp, P. N. Mwinzi, J. Scharringa, H. A. Dekker, J. A. van Strijp, R. Cherniak, and A. I. Hoepelman. 2001. Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. J. Immunol. 167:3988-3995.
21. Doering, T. L. 2000. How does Cryptococcus get its coat? Trends Microbiol. 8:547-553.
22. Ellerbroek, P. M., D. J. Lefeber, R. van Veghel, J. Scharringa, E. Brouwer, G. J. Gerwig, G. Janbon, A. I. Hoepelman, and F. E. Coenjaerts. 2004. O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. J. Immunol. 173:7513-7520.
23. Feldmesser, M., Y. Kress, and A. Casadevall. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355-2365.
24. Franzot, S. P., I. F. Salkin, and A. Casadevall. 1999. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J. Clin. Microbiol. 37:838-840.
25. Frases, S., L. Nimrichter, N. B. Viana, A. Nakouzi, and A. Casadevall. 2008. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot. Cell 7:319-327.
26. Garcia-Rivera, J., Y. C. Chang, K. J. Kwon-Chung, and A. Casadevall. 2004. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot. Cell 3:385-392.
27. Hamilton, A. J., and J. Goodley. 1996. Virulence factors of Cryptococcus neoformans. Curr. Top. Med. Mycol. 7:19-42.
28. Heiss, C., J. S. Klutts, Z. Wang, T. L. Doering, and P. Azadi. 2009. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid. Carbohydr. Res. 344:915-920.
29. James, P. G., and R. Cherniak. 1992. Galactoxylomannans of Cryptococcus neoformans. Infect. Immun. 60:1084-1088.
30. Janbon, G. 2004. Cryptococcus neoformans capsule biosynthesis and regulation. FEMS Yeast Res. 4:765-771.
31. Janbon, G., U. Himmelreich, F. Moyrand, L. Improvisi, and F. Dromer. 2001. Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol. Microbiol. 42:453-467.
32. Jong, A., C. H. Wu, H. M. Chen, F. Luo, K. J. Kwon-Chung, Y. C. Chang, C. W. Lamunyon, A. Plaas, and S. H. Huang. 2007. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot. Cell 6:1486-1496.
33. Klutts, J. S., and T. L. Doering. 2008. Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. J. Biol. Chem. 283:14327-14334.
34. Klutts, J. S., S. B. Levery, and T. L. Doering. 2007. A beta-1,2 xylosyltranferase from Cryptococcus neoformans defines a new family of glycosyltransferases. J. Biol. Chem. 282:17890-17899.
35. Kozel, T. R. 1995. Virulence factors of Cryptococcus neoformans. Trends Microbiol. 3:295-299.
36. Levitz, S. M. 1991. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13:1163-1169.
37. Levitz, S. M., D. J. DiBenedetto, and R. D. Diamond. 1987. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J. Immunol. Methods 101:37-42.
38. Lui, G., N. Lee, M. Ip, K. W. Choi, Y. K. Tso, E. Lam, S. Chau, R. Lai, and C. S. Cockram. 2006. Cryptococcosis in apparently immunocompetent patients. QJM 99:143-151.
39. McFadden, D. C., B. C. Fries, F. Wang, and A. Casadevall. 2007. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot. Cell 6:1464-1473.
40. Moyrand, F., Y. C. Chang, U. Himmelreich, K. J. Kwon-Chung, and G. Janbon. 2004. Cas3p belongs to a seven-member family of capsule structure designer proteins. Eukaryot. Cell 3:1513-1524.
41. Moyrand, F., T. Fontaine, and G. Janbon. 2007. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 64:771-781.
42. Moyrand, F., and G. Janbon. 2004. UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37°C and for capsule biosynthesis. Eukaryot. Cell 3:1601-1608.
43. Mukherjee, J., A. Casadevall, and M. D. Scharff. 1993. Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J. Exp. Med. 177:1105-1116.
44. Murphy, J. W. 1999. Immunological down-regulation of host defenses in fungal infections. Mycoses 42(Suppl. 2):37-43.
45. Perfect, J. R., B. Wong, Y. C. Chang, K. J. Kwon-Chung, and P. R. Williamson. 1998. Cryptococcus neoformans: virulence and host defences. Med. Mycol. 36(Suppl. 1):79-86.
46. Reiss, E., M. Huppert, and R. Cherniak. 1985. Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. Curr. Top. Med. Mycol. 1:172-207.
47. Rodrigues, M. L., L. Nimrichter, D. L. Oliveira, S. Frases, K. Miranda, O. Zaragoza, M. Alvarez, A. Nakouzi, M. Feldmesser, and A. Casadevall. 2007. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot. Cell 6:48-59.
48. Sommer, U., H. Liu, and T. L. Doering. 2003. An alpha-1,3-mannosyltransferase of Cryptococcus neoformans. J. Biol. Chem. 278:47724-47730.
49. Turner, S. H., R. Cherniak, and E. Reiss. 1984. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr. Res. 125:343-349.
50. Vaishnav, V. V., B. E. Bacon, M. O'Neill, and R. Cherniak. 1998. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr. Res. 306:315-330.
51. Yoneda, A., and T. L. Doering. 2006. A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol. Biol. Cell 17: 5131-5140.
52. Zebedee, S. L., R. K. Koduri, J. Mukherjee, S. Mukherjee, S. Lee, D. F. Sauer, M. D. Scharff, and A. Casadevall. 1994. Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob. Agents Chemother. 38:1507-1514.